Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024
March 16, 2024
Share
Dr. Lal PathLabs Limited announced the appointment of Shankha Banerjee as its new chief executive officer (CEO) and Key Managerial Personnel, effective from May 21, 2024. The decision was made by the company's board of directors based on the recommendations of the nomination & remuneration committee. His appointment as CEO and Key Managerial Personnel is subject to the terms and conditions governed by the company's policy.
Banerjee is an alumnus of Delhi College of Engineering and SP Jain Institute of Management & Research, Mumbai. He holds an experience spanning over two decades in the corporate sector. Prior to joining Dr. Lal PathLabs in 2014, he held leadership positions at Castrol India Limited, BP Lubricants, and Pidilite Industries Limited, where he served as President - Sales & Marketing for the Middle East and Africa regions.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
